Reversal of P-glycoprotein-medicated multidrug resistance by LBM-A5 in vitro and a study of its pharmacokinetics in vivo

Publisher： NRC Research Press

E-ISSN： 1205-7541|93|1|33-38

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.93, Iss.1, 2015-01, pp. : 33-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives

By Hayashi1 M.   Koike2 K.   Rho14 M-C.   Kuwano3 M.   Kishiye2 T.   Komiyama1 K.  

Anti-Cancer Drug Design, Vol. 16, Iss. 4, 2001-08 ,pp. : 255-260

Cognizant Communication Corporation

Access to resources Recommend Favorite

Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents

By Woodland Cindy   Koren Gideon   Wainer Irving W   Batist Gerry   Ito Shinya  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 8, 2003-08 ,pp. : 800-805

NRC Research Press

Access to resources Recommend Favorite

SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance

By Baranck M.   Bohacova V.   Kvackajova J.   Hudecova S.   Krizanova O.   Breier A.  

European Journal of Pharmaceutical Sciences, Vol. 14, Iss. 1, 2001-08 ,pp. : 29-36

Elsevier

Access to resources Recommend Favorite

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance

By  

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 813-821

Bentham Science Publishers

Access to resources Recommend Favorite

Reversal of Multidrug Resistance by the P-Glycoprotein Modulator, LY335979, from the Bench to the Clinic

By  

Current Medicinal Chemistry, Vol. 8, Iss. 1, 2001-01 ,pp. : 39-50

Bentham Science Publishers

Access to resources Recommend Favorite